文献速递复苏、休克与脓毒症重症综合管理与镇静镇痛

院外心脏骤停复苏后到达时血钾与30天生存的关联:一项回顾性队列研究

The association between arrival potassium and 30-day survival following resuscitation from out-of-hospital cardiac arrest: a retrospective cohort study.
PubMed 文献 · Scand J Trauma Resusc Emerg Med · 2025-08-26
一句话结论院外心脏骤停复苏后到达医院时高钾血症与30天生存率降低独立相关,而低钾血症与30天生存率降低无关。

该研究利用丹麦全国登记数据(2001-2019年),纳入4,894例到达医院时恢复自主循环且有复苏后血钾记录的院外心脏骤停患者,按首次血钾分为七个预设水平,以血钾正常(3.5-4.6 mmol/L)为参照,用多变量Cox回归估计30天生存。结果显示,与血钾正常相比,血钾4.7-5.5、5.5-6.0和>6.0 mmol/L组的30天生存率均显著降低(平均RR分别为0.72、0.60、0.56),而低钾血症组与血钾正常组无显著差异。该关联独立于年龄、性别、合并症负担及院前心脏骤停特征。

要点

  • 在4,894例院外心脏骤停复苏后到达医院的患者中,血钾>6.0 mmol/L组30天生存率22.7%,血钾正常组57.9%,平均RR 0.56(95%CI 0.46-0.66)。
  • 血钾4.7-5.5 mmol/L组30天生存率32.7%,平均RR 0.72(95%CI 0.66-0.78);5.5-6.0 mmol/L组22.8%,平均RR 0.60(95%CI 0.47-0.73)。
  • 低钾血症组与血钾正常组30天生存率无显著差异。
  • 高钾血症与30天生存率降低的关联独立于年龄、性别、Charlson合并症指数(包括慢性肾脏病)、目击状态、旁观者心肺复苏及首次注册心律。

适用人群与场景

  • 院外心脏骤停后到达医院时恢复自主循环(ROSC)且有复苏后血钾记录的患者(丹麦全国登记数据,2001-2019年,共4,894例)。

诊断标准与关键阈值

  • 血钾分层:<2.5、2.5-2.9、3.0-3.4、3.5-4.6(正常参照)、4.7-5.5、5.5-6.0、>6.0 mmol/L。

研究设计与关键结果

  • 研究类型:回顾性队列研究;样本量4,894例;人群:院外心脏骤停后到达医院时ROSC且有复苏后血钾记录的患者;暴露:首次记录的血钾水平;主要终点:30天生存。
  • 30天生存率:血钾<2.5 mmol/L组51.0%(25例)、2.5-2.9 mmol/L组53.6%(119例)、3.0-3.4 mmol/L组65.4%(512例)、3.5-4.6 mmol/L组57.9%(1,631例)、4.7-5.5 mmol/L组32.7%(220例)、5.5-6.0 mmol/L组22.8%(34例)、>6.0 mmol/L组22.7%(46例)。
  • 与血钾正常(3.5-4.6 mmol/L)相比,高钾血症各组30天生存率显著降低:4.7-5.5 mmol/L组平均RR 0.72(95%CI 0.66-0.78);5.5-6.0 mmol/L组平均RR 0.60(95%CI 0.47-0.73);>6.0 mmol/L组平均RR 0.56(95%CI 0.46-0.66)。
  • 低钾血症组与血钾正常组相比,30天生存率无显著差异。

证据类型、等级与局限

  • 证据类型:回顾性队列研究;局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,在院外心脏骤停幸存者中,高钾血症与30天生存率降低相关,且独立于年龄、性别、合并症负担及院前心脏骤停特征;低钾血症与30天生存率降低无关。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: It is unknown whether there is an association between initial serum potassium level and short-term survival in out-of-hospital cardiac arrest (OHCA) survivors. The aim of this study was to describe potential associations between first recorded potassium level and 30-day survival in patients surviving OHCA.

METHODS: We identified 4,894 patients who had return of spontaneous circulation (ROSC) at hospital arrival, and a registered post-OHCA serum-potassium value, using Danish nationwide registry data from 2001-2019. Potassium values were divided into seven predefined levels: < 2.5, 2.5-2.9, 3.0-3.4, 3.5-4.6, 4.7-5.5, 5.5-6.0, > 6.0 mmol/L. Thirty-day survival was estimated using a multivariable Cox regression (reference normokalemia 3.5-4.6 mmol/L). The multivariable model included age, sex, Charlson comorbidity index (including chronic kidney disease), witnessed status, performance of bystander cardiopulmonary resuscitation (CPR) and first registered heart rhythm.

RESULTS: Over the 30-day follow-up period, survival rates in the seven strata were as follows: 25 (51.0%), 119 (53.6%), 512 (65.4%), 1,631 (57.9%), 220 (32.7%), 34 (22.8%), and 46 (22.7%), respectively. Thirty-day survival was significantly lower for all groups with hyperkalemia compared with normokalemia: 4.7-5.5 mmol/L: (average risk ratio (RR): 0.72, 95% confidence interval (95% CI): 0.66-0.78); 5.5-6.0 mmol/L: (average RR: 0.60, 95% CI: 0.47-0.73); > 6.0 mmol/L: (average RR: 0.56, 95% CI: 0.46-0.66). Survival did not differ significantly in patients with hypokalemia compared with normokalemia.

CONCLUSIONS: In OHCA survivors, hyperkalemia was associated with reduced 30-day survival compared with normokalemia, independent of age, sex, comorbidity burden and pre-hospital OHCA-characteristics. Conversely, hypokalemia was not associated with reduced 30-day survival.

来源:Scand J Trauma Resusc Emerg Med,查看原文。版权归原作者所有。

参考来源

  1. Byrne C, Krogager ML, Kragholm K, et al. The association between arrival potassium and 30-day survival following resuscitation from out-of-hospital cardiac arrest: a retrospective cohort study. Scand J Trauma Resusc Emerg Med. 2025. PMID: 40859315. doi:10.1186/s13049-025-01454-8

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。